October 2026 is Breast Cancer Awareness Month – find out more about HQIP’s work on...

October 2026 is Breast Cancer Awareness Month – find out more about HQIP’s work on...

Back in September 2020 we presented the UK’s first Hereditary Cancer Awareness Week, a time dedicated to raising awareness and sharing information about hereditary cancer.

For more information about NATCAN, the data we use, participation in the audits, and audit reporting, please visit our general FAQs here. About NNHLA Trust Participation Methodology and Reporting Pati...

Become a Member of AUGIS

Dixon L, Cook S, Cook A, Thomas J, Boudour J, Chan F, Cromwell D, West D, Navani N, Conibear J

National Cancer Audit Collaborating Centre (NATCAN),National Non-Hodgkin Lymphoma Audit (NNHLA) Based on data between 1 January 2023 and 31 December 2023 in England, and 1 January 2024 and 31 December 2024 in Wales, this report assesses diagnosis, treatment, toxicity and outcomes for people with non-Hodgkin lymphoma (NHL). It found that emergency presentation remains common, while delays and treatment toxicity concerns remain. Non-Hodgkin lymphoma State of the Nation report 2026

National Audit of Metastatic Breast Cancer (NAoMe),National Cancer Audit Collaborating Centre (NATCAN) This report reviews care for people with newly diagnosed metastatic breast cancer (MBC) across England and Wales between 2021 and 2023. It found that survival differed substantially by tumour subtype, and access to cyclin dependent kinase (CDK) 4/6 inhibitors varied considerably. More specifically, use differed according to patient age.

National Cancer Audit Collaborating Centre (NATCAN),National Oesophago-Gastric Cancer Audit (NOGCA) This report is an audit of care received by people diagnosed with oesophageal or gastric cancer between 1 January 2023 and 31 December 2024 in England and Wales. It reviews diagnosis, treatment and outcomes, finding that many patients present with advanced disease, and treatment delays remain significant. Only 67% of fit English stage 1-3 patients received curative treatment. Oesophago-gastric cancer State of the Nation report 2026

National Audit of Primary Breast Cancer (NAoPri),National Cancer Audit Collaborating Centre (NATCAN) This report assesses the quality of care for people diagnosed with primary breast cancer in England and Wales between 2021 and 2023. Overall, 67.4% of people diagnosed outside breast screening were recorded as diagnosed through triple diagnostic assessment (TDA) clinic, with rates ranging from 5.3% to 89.3% according to organisation of diagnosis. Primary breast cancer State of the Nation report 2026

National Pancreatic Cancer Audit (NPaCA),National Cancer Audit Collaborating Centre (NATCAN) This report, which evaluates pancreatic cancer diagnosis, treatment, supportive care and outcomes, is an audit of care received by people diagnosed with pancreatic cancer. It found that most patients are diagnosed late, and treatment and supportive care remain variable. Overall, survival remains low, with one-year survival at 23% in England and Wales, and two-year survival at 11% in England. Pancreatic cancer State of the Nation report 2026